US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 2.2100
  • 0.00000.00%
Close Jun 4 16:00 ET
  • 2.1603
  • -0.0497-2.25%
Post 16:06 ET
144.68MMarket Cap-1524P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
19.77%8.83M
10.16%31.11M
19.73%8.3M
7.43%8.13M
1.95%7.32M
12.18%7.37M
1.52%28.24M
-0.40%6.93M
-10.17%7.56M
8.09%7.18M
Selling and administrative expenses
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
-10.02%2.25M
-0.84%2.47M
-General and administrative expense
13.99%2.79M
1.30%9.96M
14.33%2.54M
17.04%2.64M
-5.19%2.34M
-15.43%2.44M
-1.93%9.83M
-13.01%2.22M
-10.02%2.25M
-0.84%2.47M
Research and development costs
22.64%6.04M
14.89%21.15M
22.28%5.76M
3.35%5.49M
5.69%4.98M
33.87%4.93M
3.46%18.41M
6.89%4.71M
-10.23%5.31M
13.45%4.71M
Operating profit
-19.77%-8.83M
-10.16%-31.11M
-19.73%-8.3M
-7.43%-8.13M
-1.95%-7.32M
-12.18%-7.37M
-1.52%-28.24M
0.40%-6.93M
10.17%-7.56M
-8.09%-7.18M
Net non-operating interest income expense
55.22%357K
1,392.77%1.07M
74.45%239K
2,408.33%301K
465.06%303K
254.36%230K
-1,022.22%-83K
179.19%137K
105.74%12K
-113.72%-83K
Non-operating interest income
5.54%438K
177.19%1.68M
6.01%353K
134.22%438K
496.20%471K
6,816.67%415K
-29.98%605K
712.20%333K
18,600.00%187K
-90.38%79K
Non-operating interest expense
-56.22%81K
-12.21%604K
-41.84%114K
-21.71%137K
3.70%168K
19.35%185K
-19.53%688K
-8.41%196K
-16.67%175K
-25.00%162K
Other net income (expense)
Income before tax
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.39%-7.01M
-6.27%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
-20.30%-7.26M
Income tax
0.00%1K
0
0
1K
0.00%1K
0
0
0
Net income
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
-20.29%-7.26M
Net income continuous Operations
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
-20.29%-7.26M
Minority interest income
Net income attributable to the parent company
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
-20.29%-7.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.63%-8.47M
-6.05%-30.04M
-18.63%-8.06M
-3.62%-7.82M
3.38%-7.01M
-6.25%-7.14M
-1.85%-28.32M
4.74%-6.8M
12.48%-7.55M
-20.29%-7.26M
Basic earnings per share
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
49.49%-0.5
35.90%-0.5
Diluted earnings per share
30.95%-0.29
15.05%-1.58
2.50%-0.39
20.00%-0.4
26.00%-0.37
8.70%-0.42
42.59%-1.86
42.86%-0.4
49.49%-0.5
35.90%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 19.77%8.83M10.16%31.11M19.73%8.3M7.43%8.13M1.95%7.32M12.18%7.37M1.52%28.24M-0.40%6.93M-10.17%7.56M8.09%7.18M
Selling and administrative expenses 13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M-10.02%2.25M-0.84%2.47M
-General and administrative expense 13.99%2.79M1.30%9.96M14.33%2.54M17.04%2.64M-5.19%2.34M-15.43%2.44M-1.93%9.83M-13.01%2.22M-10.02%2.25M-0.84%2.47M
Research and development costs 22.64%6.04M14.89%21.15M22.28%5.76M3.35%5.49M5.69%4.98M33.87%4.93M3.46%18.41M6.89%4.71M-10.23%5.31M13.45%4.71M
Operating profit -19.77%-8.83M-10.16%-31.11M-19.73%-8.3M-7.43%-8.13M-1.95%-7.32M-12.18%-7.37M-1.52%-28.24M0.40%-6.93M10.17%-7.56M-8.09%-7.18M
Net non-operating interest income expense 55.22%357K1,392.77%1.07M74.45%239K2,408.33%301K465.06%303K254.36%230K-1,022.22%-83K179.19%137K105.74%12K-113.72%-83K
Non-operating interest income 5.54%438K177.19%1.68M6.01%353K134.22%438K496.20%471K6,816.67%415K-29.98%605K712.20%333K18,600.00%187K-90.38%79K
Non-operating interest expense -56.22%81K-12.21%604K-41.84%114K-21.71%137K3.70%168K19.35%185K-19.53%688K-8.41%196K-16.67%175K-25.00%162K
Other net income (expense)
Income before tax -18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.39%-7.01M-6.27%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M-20.30%-7.26M
Income tax 0.00%1K001K0.00%1K000
Net income -18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M-20.29%-7.26M
Net income continuous Operations -18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M-20.29%-7.26M
Minority interest income
Net income attributable to the parent company -18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M-20.29%-7.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.63%-8.47M-6.05%-30.04M-18.63%-8.06M-3.62%-7.82M3.38%-7.01M-6.25%-7.14M-1.85%-28.32M4.74%-6.8M12.48%-7.55M-20.29%-7.26M
Basic earnings per share 30.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.449.49%-0.535.90%-0.5
Diluted earnings per share 30.95%-0.2915.05%-1.582.50%-0.3920.00%-0.426.00%-0.378.70%-0.4242.59%-1.8642.86%-0.449.49%-0.535.90%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg